C CELL MATTERS UNLEASHING YOUR CELL THERAPY
Live / Registered — Registered (as of 13 Sept 2022)
What this means for you
Registered since 13 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90835684
- Registration number
- 6843055
- Mark type
- Design + words
- Filed
- 19 Jul 2021
- Published for opposition
- 28 Jun 2022
- Registered
- 13 Sept 2022
- Attorney of record
- Dana Dickson
Goods and services
- Class 001 — Chemicals: Cryogenic preparations in liquid state for use in chilling and freezing for medical research purposes; preparations for cryopreservation of cells for medical research purposes, in particular cryopreservative buffers and molecules for use in chilling and freezing of cells for medical research purposes; cell culture media for laboratory, scientific, and research use
- Class 005 — Pharmaceuticals: vitrification solutions, namely, cryogenic preparations in liquid state for use in chilling and freezing of cells for medical purposes; Reagents for medical purposes; Preparations for cryopreservation of cells for medical purposes, in particular cryopreservative buffers and molecules for use in chilling and freezing of cells for medical purposes; biological tissue cultures for medical and veterinary use; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations for the treatment of wounds; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for the treatment of hypertension; Pharmaceutical preparations for the treatment of tumors, namely, for suppressing tumors; Pharmaceutical preparations for the treatment of chemical imbalances; Veterinary pharmaceutical preparations for the prevention of animal skin disorders; culture medium for cultivating bacteriological and human cell cultures; cellular preparations for medical, pharmaceutical or veterinary use and in particular for gene therapy and for cell therapy, namely, stem cells for medical use, living cells for medical and veterinary use, and genetically engineered tissues for transplant purposes
- Class 039 — Transportation and storage services: Storage services for human cells and tissues and other biological material for medical, therapeutic, biotechnological use
- Class 040 — Treatment of materials: Treatment of biomaterials for the manufacture of products for others by means of cryogenic processing; cryogenic preservation of pharmaceutical products; Cryopreservation services; Custom assembly of materials for others; Contract manufacturing of bio-chemical and pharmaceutical products for third parties
- Class 042 — Scientific and technological services: Research and development of new products for others; Product engineering consultancy services; Research and development of pharmaceutical products; scientific and applied research and development, in particular in the biological, technological and biotechnological fields and in particular in the fields of gene and cell therapy; quality control services; culturing of stem cells, differentiated cells, and human tissue cells for others, for use in cell therapy and for scientific and research purposes; Biotechnology and medical cell therapy research consultancy services
- Class 044 — Medical, beauty and agricultural services: Stem cell therapy consultancy services
Owner
- CELL MATTERS S.A., Liège, BE
- CELL MATTERS S.A., Liège, BE
- CELL MATTERS S.A., Liège, BE
Prosecution history
- 16 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Jan 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 16 Jan 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 28 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jun 2022 — PUBLISHED FOR OPPOSITION
- 08 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 May 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 May 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 May 2022 — ASSIGNED TO LIE
- 28 Apr 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Apr 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Apr 2022 — NON-FINAL ACTION E-MAILED